{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:17:30Z","timestamp":1771424250305,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021771","name":"Student Research Committee, Tabriz University of Medical Sciences","doi-asserted-by":"crossref","award":["73269"],"award-info":[{"award-number":["73269"]}],"id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021771","name":"Student Research Committee, Tabriz University of Medical Sciences","doi-asserted-by":"crossref","award":["73269"],"award-info":[{"award-number":["73269"]}],"id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021771","name":"Student Research Committee, Tabriz University of Medical Sciences","doi-asserted-by":"crossref","award":["73269"],"award-info":[{"award-number":["73269"]}],"id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04627-9","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:55:14Z","timestamp":1769522114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic and biomarker potential of erythropoietin in neurodegenerative diseases: a systematic review"],"prefix":"10.1186","volume":"26","author":[{"given":"Maryam","family":"Babazadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarvin","family":"Sanaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sama","family":"Rahnemayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"4627_CR1","doi-asserted-by":"crossref","unstructured":"Logroscino G, Tortelli R. Epidemiology of neurodegenerative diseases. Imaging Neurodegenerative Disorders. 2014;6(1).","DOI":"10.1093\/med\/9780199671618.003.0001"},{"key":"4627_CR2","doi-asserted-by":"crossref","unstructured":"Sharma S, Priya T, Goel N, Kashyap D, Garg VK. Overview of neurodegenerative disorders. Data Analysis for Neurodegenerative Disorders: Springer; 2023. pp. 3\u201312.","DOI":"10.1007\/978-981-99-2154-6_1"},{"key":"4627_CR3","doi-asserted-by":"publisher","first-page":"8590578","DOI":"10.1155\/2016\/8590578","volume":"2016","author":"S Manoharan","year":"2016","unstructured":"Manoharan S, Guillemin GJ, Abiramasundari RS, Essa MM, Akbar M, Akbar MD. The role of reactive oxygen species in the pathogenesis of alzheimer\u2019s Disease, parkinson\u2019s Disease, and huntington\u2019s disease: A mini review. Oxid Med Cell Longev. 2016;2016:8590578.","journal-title":"Oxid Med Cell Longev"},{"issue":"6248","key":"4627_CR4","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","volume":"349","author":"M Goedert","year":"2015","unstructured":"Goedert M. NEURODEGENERATION. Alzheimer\u2019s and parkinson\u2019s diseases: the prion concept in relation to assembled Abeta, tau, and alpha-synuclein. Science. 2015;349(6248):1255555.","journal-title":"Science"},{"issue":"1","key":"4627_CR5","doi-asserted-by":"publisher","first-page":"e12295","DOI":"10.1002\/trc2.12295","volume":"8","author":"J Cummings","year":"2022","unstructured":"Cummings J, Lee G, Nahed P, Kambar M, Zhong K, Fonseca J, et al. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimers Dement (N Y). 2022;8(1):e12295.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"8","key":"4627_CR6","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s11064-022-03617-w","volume":"47","author":"TT Nguyen","year":"2022","unstructured":"Nguyen TT, Bao NS, Van Vo G. Advances in Hydrogel-Based drug delivery systems for parkinson\u2019s disease. Neurochem Res. 2022;47(8):2129\u201341.","journal-title":"Neurochem Res"},{"issue":"6","key":"4627_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrn1687","volume":"6","author":"M Brines","year":"2005","unstructured":"Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 2005;6(6):484\u201394.","journal-title":"Nat Rev Neurosci"},{"key":"4627_CR8","doi-asserted-by":"publisher","first-page":"175909141987142","DOI":"10.1177\/1759091419871420","volume":"11","author":"F Rey","year":"2019","unstructured":"Rey F, Balsari A, Giallongo T, Ottolenghi S, Di Giulio AM, Samaja M, et al. Erythropoietin as a neuroprotective molecule: an overview of its therapeutic potential in neurodegenerative diseases. ASN Neuro. 2019;11:1759091419871420.","journal-title":"ASN Neuro"},{"issue":"5","key":"4627_CR9","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.neuro.2005.01.016","volume":"26","author":"S Bartesaghi","year":"2005","unstructured":"Bartesaghi S, Marinovich M, Corsini E, Galli CL, Viviani B. Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology. 2005;26(5):923\u20138.","journal-title":"Neurotoxicology"},{"key":"4627_CR10","doi-asserted-by":"publisher","first-page":"102223","DOI":"10.1016\/j.redox.2021.102223","volume":"49","author":"B Cho","year":"2022","unstructured":"Cho B, Yoo SJ, Kim SY, Lee CH, Lee YI, Lee SR, et al. Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection. Redox Biol. 2022;49:102223.","journal-title":"Redox Biol"},{"issue":"5","key":"4627_CR11","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00221-022-06331-9","volume":"240","author":"CM Sergio","year":"2022","unstructured":"Sergio CM, Rolando CA. Erythropoietin regulates signaling pathways associated with neuroprotective events. Exp Brain Res. 2022;240(5):1303\u201315.","journal-title":"Exp Brain Res"},{"key":"4627_CR12","doi-asserted-by":"publisher","first-page":"1346390","DOI":"10.1155\/2016\/1346390","volume":"2016","author":"O Dmytriyeva","year":"2016","unstructured":"Dmytriyeva O, Pankratova S, Korshunova I, Walmod PS. Epobis is a Nonerythropoietic and neuroprotective agonist of the erythropoietin receptor with Anti-Inflammatory and memory enhancing effects. Mediators Inflamm. 2016;2016:1346390.","journal-title":"Mediators Inflamm"},{"issue":"3","key":"4627_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s42255-023-00756-4","volume":"5","author":"Y Mi","year":"2023","unstructured":"Mi Y, Qi G, Vitali F, Shang Y, Raikes AC, Wang T, et al. Loss of fatty acid degradation by astrocytic mitochondria triggers neuroinflammation and neurodegeneration. Nat Metab. 2023;5(3):445\u201365.","journal-title":"Nat Metab"},{"issue":"1","key":"4627_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1203\/00006450-199801000-00007","volume":"43","author":"SE Juul","year":"1998","unstructured":"Juul SE, Anderson DK, Li Y, Christensen RD. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res. 1998;43(1):40\u20139.","journal-title":"Pediatr Res"},{"issue":"41","key":"4627_CR15","doi-asserted-by":"publisher","first-page":"14907","DOI":"10.1073\/pnas.0406491101","volume":"101","author":"M Brines","year":"2004","unstructured":"Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, et al. Erythropoietin mediates tissue protection through an erythropoietin and common \u03b2-subunit heteroreceptor. Proc Natl Acad Sci. 2004;101(41):14907\u201312.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"4627_CR16","doi-asserted-by":"publisher","first-page":"e25051","DOI":"10.1016\/j.heliyon.2024.e25051","volume":"10","author":"F Fussing","year":"2024","unstructured":"Fussing F, Christensson J, Wortwein G. Expression of erythropoietin receptor protein in the mouse hippocampus in response to Normobaric hypoxia. Heliyon. 2024;10(3):e25051.","journal-title":"Heliyon"},{"issue":"1","key":"4627_CR17","first-page":"49","volume":"23","author":"M Garcia-Llano","year":"2021","unstructured":"Garc\u00eda-Llano M, Pedroso-Ib\u00e1\u00f1ez I, Morales-Chac\u00f3n L, Rodr\u00edguez-Obaya T, P\u00e9rez-Ruiz L, Sosa-Test\u00e9 I, et al. Short-term tolerance of Nasally-administered neuroepo in patients with Parkinson disease. MEDICC Rev. 2021;23(1):49\u201354.","journal-title":"MEDICC Rev"},{"issue":"3\u20134","key":"4627_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1023\/B:MEBR.0000043969.96895.3c","volume":"19","author":"H Ehrenreich","year":"2004","unstructured":"Ehrenreich H, Aust C, Krampe H, Jahn H, Jacob S, Herrmann M, et al. Erythropoietin: novel approaches to neuroprotection in human brain disease. Metab Brain Dis. 2004;19(3\u20134):195\u2013206.","journal-title":"Metab Brain Dis"},{"key":"4627_CR19","doi-asserted-by":"publisher","first-page":"841538","DOI":"10.3389\/fphar.2022.841538","volume":"13","author":"M Brines","year":"2022","unstructured":"Brines M, Carelli S, Samaja M, Schneider Gasser EM. Editorial: erythropoietin and its analogues as therapeutics for neurological diseases. Front Pharmacol. 2022;13:841538.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4627_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13195-024-01666-7","volume":"17","author":"JL Cummings","year":"2025","unstructured":"Cummings JL, Atri A, Feldman HH, Hansson O, Sano M, Knop FK, et al. Evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic alzheimer\u2019s disease. Alzheimers Res Ther. 2025;17(1):14.","journal-title":"Alzheimers Res Ther"},{"key":"4627_CR21","unstructured":"Aromataris E, Fernandez R, Godfrey C, Holly C, Khalil H, Tungpunkom P. Methodology for JBI umbrella reviews. 2014."},{"issue":"1","key":"4627_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181fe7999","volume":"22","author":"B Takkouche","year":"2011","unstructured":"Takkouche B, Norman G. PRISMA statement. Epidemiology. 2011;22(1):128.","journal-title":"Epidemiology"},{"issue":"3","key":"4627_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.11124\/JBIES-22-00430","volume":"21","author":"THSJ Barker","year":"2023","unstructured":"Barker THSJ, Sears K, Klugar M, Tufanaru C, Leonardi-Bee J, Aromataris E, Munn Z. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid Synthesis. 2023;21(3):494\u2013506.","journal-title":"JBI Evid Synthesis"},{"issue":"3","key":"4627_CR24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.11124\/JBIES-23-00268","volume":"22","author":"THHN Barker","year":"2024","unstructured":"Barker THHN, Aromataris E, Stone JC, Leonardi-Bee J, Sears K, et al. The revised JBI critical appraisal tool for the assessment of risk of bias quasi-experimental studies. JBI Evid Synth. 2024;22(3):378\u201388.","journal-title":"JBI Evid Synth"},{"key":"4627_CR25","volume-title":"Joanna Briggs Institute reviewer\u2019s manual","author":"SMZ Moola","year":"2017","unstructured":"Moola SMZ, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P. Lisy K MP-F. Chapter 7: systematic reviews of etiology and risk. In: Aromataris EMZ, editor. Joanna Briggs Institute reviewer\u2019s manual. Adelaide, South Australia: The Joanna Briggs Institute; 2017."},{"key":"4627_CR26","doi-asserted-by":"crossref","unstructured":"Sosa S, Bringas G, Urrutia N, Pe\u00f1alver AI, L\u00f3pez D, Gonz\u00e1lez E et al. NeuroEPO plus (NeuralCIM\u00ae) in mild-to-moderate Alzheimer\u2019s clinical syndrome: the ATHENEA randomized clinical trial. Alzheimer\u2019s Res Therapy. 2023;15(1).","DOI":"10.1186\/s13195-023-01356-w"},{"key":"4627_CR27","doi-asserted-by":"crossref","unstructured":"Pedroso I, Garcia M, Casabona E, Morales L, Bringas ML, P\u00e9rez L et al. Protective activity of erythropoyetine in the cognition of patients with Parkinson\u2019s disease. Behav Sci. 2018;8(5).","DOI":"10.3390\/bs8050051"},{"issue":"1\u20132","key":"4627_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jns.2013.11.015","volume":"337","author":"W Jang","year":"2014","unstructured":"Jang W, Park J, Shin KJ, Kim JS, Kim JS, Youn J, et al. Safety and efficacy of Recombinant human erythropoietin treatment of non-motor symptoms in parkinson\u2019s disease. J Neurol Sci. 2014;337(1\u20132):47\u201354.","journal-title":"J Neurol Sci"},{"issue":"4","key":"4627_CR29","doi-asserted-by":"publisher","first-page":"e0248800","DOI":"10.1371\/journal.pone.0248800","volume":"16","author":"BR Jensen","year":"2021","unstructured":"Jensen BR, Malling ASB, Schmidt SI, Meyer M, Morberg BM, Wermuth L. Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in parkinson\u2019s disease. PLoS ONE. 2021;16(4):e0248800.","journal-title":"PLoS ONE"},{"issue":"1","key":"4627_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.37757\/MR2012V14.N1.4","volume":"14","author":"I Pedroso","year":"2012","unstructured":"Pedroso I, Bringas Vega ML, Aguiar A, Morales L, \u00c1lvarez M, Vald\u00e9s PA, et al. Use of Cuban Recombinant human erythropoietin in parkinson\u2019s disease treatment. MEDICC Rev. 2012;14(1):11\u20137.","journal-title":"MEDICC Rev"},{"issue":"17","key":"4627_CR31","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.18632\/aging.102227","volume":"11","author":"PH Hung","year":"2019","unstructured":"Hung PH, Yeh CC, Sung FC, Hsiao CY, Muo CH, Hung KY, et al. Erythropoietin prevents dementia in Hemodialysis patients: a nationwide population-based study. Aging. 2019;11(17):6941\u201350.","journal-title":"Aging"},{"issue":"11","key":"4627_CR32","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/pcn.12777","volume":"72","author":"R Kumagai","year":"2018","unstructured":"Kumagai R, Koike M, Iwase Y, Ichimiya Y. Erythropoietin Preparation drastically improved activities of daily living in a patient with severe dementia. Psychiatry Clin Neurosci. 2018;72(11):849.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"4627_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/nen.0b013e3180517b28","volume":"66","author":"MI Assaraf","year":"2007","unstructured":"Assaraf MI, Diaz Z, Liberman A, Miller WH Jr, Arvanitakis Z, Li Y, et al. Brain erythropoietin receptor expression in alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol. 2007;66(5):389\u201398.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"4627_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.neulet.2006.06.011","volume":"404","author":"J Brettschneider","year":"2006","unstructured":"Brettschneider J, Widl K, Ehrenreich H, Riepe M, Tumani H. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neurosci Lett. 2006;404(3):347\u201351.","journal-title":"Neurosci Lett"},{"issue":"2","key":"4627_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/mds.1063","volume":"16","author":"AS Winkler","year":"2001","unstructured":"Winkler AS, Marsden J, Parton M, Watkins PJ, Chaudhuri KR. Erythopoietin defficiency and anaemia in multiple system atrophy. Mov Disord. 2001;16(2):233\u20139.","journal-title":"Mov Disord"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04627-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04627-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04627-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:56:20Z","timestamp":1771422980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04627-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4627"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04627-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted on previously published material, with no direct patient contact. The protocol is registered on PROSPERO (registration code: CRD42024595646).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}